D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester

 化学構造式
1326302-97-9
CAS番号.
1326302-97-9
化学名:
别名:
英語名:
D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester
英語别名:
D4.2;Rosuvastatin Impurity 196;Cholecalciferol Impurity 25;Tert-butyl 2-(2,2-dimethyl-6-(((5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl)methyl)-1,3-dioxa n-4-yl)acetate (D4-2) ;1,1-Dimethylethyl 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-D-erythro-hexonate;D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester
CBNumber:
CB98135046
化学式:
C16H26N2O6S2
分子量:
406.52
MOL File:
1326302-97-9.mol

D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester 物理性質

沸点 :
516.5±48.0 °C(Predicted)
比重(密度) :
1.218±0.06 g/cm3(Predicted)
酸解離定数(Pka):
-3.55±0.10(Predicted)

安全性情報

D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester 化学特性,用途語,生産方法

D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester 上流と下流の製品情報

原材料

準備製品


D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester 生産企業

Global( 10)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Neostar United (Changzhou) Industrial Co., Ltd.
+86-0519-85551759 +8613506123987
marketing1@neostarunited.com China 8838 58
ShenZhen H&D Pharmaceutical Technology Co., LTD
+8618627948422
sale@hdimpurity.com China 3389 58
Jiangsu Greature Bio-Medicine Co., Ltd. 0512-85557988 18662338937
frank.wang@greature.com.cn China 97 58
Lead Biotech (Hangzhou) Co., Ltd 0571-56190693 18657131631
jian.wang@leadbiotech.com China 58 55
Molcoo Chemicals Inc. 18672515910
3001051413@qq.com China 9447 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 39990 58
SHANDONGQIANGSENHUAGONG 0533-18369966222-222 18369966222
3034942636@qq.com China 922 58
guoyungurui 18162595016; 18162595016
3287908757@qq.com China 10336 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 13217415044
2881949741@qq.com China 4989 58
Hubei Hengluyuan Technology co.ltd 027-88188016 18717196322
1764683941@qq.com China 5672 58

  • 1326302-97-9
  • D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester
  • D4.2
  • Cholecalciferol Impurity 25
  • Rosuvastatin Impurity 196
  • Tert-butyl 2-(2,2-dimethyl-6-(((5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl)methyl)-1,3-dioxa n-4-yl)acetate (D4-2)
  • 1,1-Dimethylethyl 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-D-erythro-hexonate
Copyright 2017 © ChemicalBook. All rights reserved